US EditionPfizer agrees to lower prescription drug costs for Medicaid in a deal with Trump
Pfizer will cut prices on most drugs for Medicaid and new medicines, with discounts averaging 50% via the new TrumpRx site, aiming to reduce U.S. drug costs by linking to lowest global prices.
- Pfizer has agreed to lower prescription drug costs for Medicaid under a deal with the Trump administration, announced by President Donald Trump.
- The deal includes most-favored-nation pricing for Medicaid and a commitment from Pfizer to spend $70 billion on domestic manufacturing.
- Patients are expected to see lower prices as part of this agreement, starting in 2026, benefiting those without insurance or those negotiating for better deals.
- Trump emphasized that this is a significant step in reversing high drug prices in the U.S., which he claims are often three times higher than in other developed nations.
461 Articles
461 Articles
Trump Announces Pfizer Deal Offering Discounts On Medicines Via 'TrumpRx' Website
Pfizer has agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the Trump administration, President Donald Trump said Tuesday as he promised similar deals with other drugmakers under the threat of tariffs.
Under pressure from Donald Trump, Pfizer cuts prices on some drugs in the US
Yielding to demands from Washington, the pharmaceutical company has agreed to lower the price of medications available under public health insurance program Medicaid in exchange for a three-year exemption from tariffs.
Why Pfizer Stock Trounced the Market Today @themotleyfool #stocks $PFE
Key PointsInvestors continued to be positive on the pharmaceutical giant following a deal reached with the government.Among other benefits, it will have a reprieve from potential tariffs on its industry.10 stocks we like better than Pfizer › Still basking in the glow of a likely advantageous deal it signed with the government the previous day, Pfizer's (NYSE: PFE) stock was extremely healthy on Hump Day. That positive sentiment was boosted by a …
Pfizer strikes deal with Trump to cut U.S. drug prices | Honolulu Star-Advertiser
WASHINGTON >> Pfizer and President Donald Trump on Tuesday said they had cut a deal in which the U.S.-based drugmaker agreed to lower prescription drug prices in the Medicaid program to what it charges in other developed countries in exchange for tariff relief.
Greek CEO of Pfizer, Albert Bourla, Signs Deal With Trump to Lower Drug Prices
US President Donald Trump shakes hands with Pfizer CEO Albert Bourla (R) during an announcement in the Oval Office at the White House. Credit: Francis Chung / EPA via AMNA In a major development for US healthcare, President Donald Trump and Greek CEO of Pfizer Albert Bourla announced a groundbreaking agreement to reduce prescription drug prices for American patients. The announcement, made from the Oval Office on Tuesday, signals a significant s…
Coverage Details
Bias Distribution
- 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
